Proteins, Antibodies & ADCs

PART OF NEXTGEN BIOMED 2025

12 - 14 March 2025 | London, UK

Programme Summary

Join leading scientific experts within proteins & antibodies, addressing critical strategies and the latest technological advancements in antibody discovery, nextgen therapeutics development, analytics and upstream & downstream bioprocessing updates. 

Hear from past attendees of last year's Biologics 2024 conference

What's New for 2025?

Gain valuable insights into novel strategies for cell line development & optimisation. Presentations will cover transposase mediated cell line generation, cell culturing techniques and advancing viral vector production through cell line development and engineering.

Gain a comprehensive understanding of downstream development for antibodies and Fc containing molecules. From Intensifying processes to improve productivity and reduce processing time, through to addressing protein aggregation challenges and single use technologies.

Discuss the latest novel tools & technologies for the display of biologics. Key opinion leaders will present on how to address difficult targets with display technologies as well as developing novel in vitro display technologies for antibody discovery & engineering.

Tap into the latest in ADC optimisation to enhance therapeutic potential through exciting sessions on linker / payload technologies, conjugation strategies and more.

NextGen Biomed - What to Expect Presenting 2
NextGen Biomed - What to Expect Exhibiting 5
NextGen Biomed - What to Expect Networking 4
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

Agenda at a Glance

Proteins, Antibodies & ADCs

DAY ONE - 12 MARCH

Track 1: Antibody Discovery & Selection: Novel Tools & Technologies
Track 2: ADC Design, Validation & Optimization to Enhance Their Therapeutic Potential
Track 3: Analytical Development: Stability & In-Depth Characterisation Methods for Proteins & Antibodies
Track 4: Upstream Development of Proteins & Antibodies

DAY TWO - 13 MARCH

Track 1: Antibody Engineering & Selection
Track 2: New Formats: Cytokines, Immunocytokines & Novel Therapeutic Formats
Track 3: Emerging Analytical Techniques, Developability & Quality Control Systems

DAY THREE - 14 MARCH

Track 1: AI/ML-Guided Protein & Antibody Engineering
Track 2: NextGen Multi-Specifics, Cell Engagers & Other New Modalities
Track 3: Downstream Development Protein Purification & Recombinant Protein Production

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Register Now

Be part of the new wave of Biomed R&D innovation

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients